Évaluation de la fonction ventriculaire droite avant implantation d'une assistance ventriculaire mono-gauche chez les patients en insuffisance cardiaque terminale par échocardiographie : combinaison de paramètres ventriculaires gauches et droits Summary Background. -Right ventricular failure (RVF) is a major cause of morbidity and mortality in left ventricular assist device (LVAD) recipients.
Background
Ventricular assist devices (VADs) are a life-saving therapeutic option for patients with end-stage heart failure.
One-year survival after implantation of a left ventricular assist device (LVAD) in selected patients is similar to that after heart transplant [1] ,10 although survival is limited by early morbidity and mortality caused by right ventricular failure (RVF) [2, 3] . Indeed, RVF failure has an incidence of up to 50% after LVAD implantation and results in perioperative mortality and morbidity rates of 19 to 43%, including end-organ dysfunction associated with prolonged intensive care and hospitalization [2, 4, 5] .
Numerous factors contribute to RVF after LVAD implantation, rendering the prediction and management of postoperative right ventricular (RV) dysfunction complex [2, [4] [5] [6] . The identification of predictors of RVF in preoperative VAD patients would improve the selection of patients most likely to benefit from LVAD.
Various clinical factors (being female, non-ischaemic aetiology of LV dysfunction) and haemodynamic factors (high central venous pressure, low mean pulmonary artery pressure and low RV stroke work index) have been identified as independent predictors of RVF after LVAD implantation [1] [2] [3] [4] [5] [6] [7] . However, no single factor reliably predicts RVF in these conditions. Risk scores, based on the independent predictors of RVF, combining clinical, haemodynamic and laboratory measurements, may be useful for predicting RVF, but no score of this type has been tested prospectively [4, 5] . The Michigan RV score can be useful in very severely affected patients, with high scores reflecting multiple organ failure (requirement for vasopressors, renal and hepatic congestion), but its utility is limited in less severe cases [4, 7] .
RV echocardiographic variables, including twodimensional global strain imaging, have been reported to provide valuable information about RV risk, but conflicting results have been obtained [8] [9] [10] [11] . The complex geometry of the right ventricle (RV) also makes it difficult to assess RV function.
Left ventricular (LV) evaluation may be useful for RVF prediction [12] . Severe and advanced LV dysfunction has consequences for RV function, and impaired LV contractility has a negative effect on RV function. Left-sided heart disease causes pulmonary venous congestion and pulmonary venous hypertension. Chronic sustained high blood pressure in pulmonary capillaries leads to a cascade of pathological retrograde anatomical and functional effects, resulting in RV overload and failure [13] . It may, therefore, be possible to predict the likelihood of RVF after LVAD implantation, at least partially, from assessments of LV function. In particular, tissue Doppler systolic myocardial velocity and the E wave, an indicator of LV relaxation disorder and overload, may be useful.
The main aim of this study was to identify preoperative echocardiographic predictors of post-LVAD RVF and to evaluate a risk score for postoperative RVF.
Methods

Study
This study complied with the Helsinki Declaration and was approved by the ethics committee of our institution. Informed consent was not sought from the patients, as this was an observational study and did not involve any changes to diagnostic tests or therapeutic interventions.
Patient selection
Data were collected prospectively for all patients who underwent elective LVAD or biventricular VAD (BiVAD) implantation and preoperative echocardiography between November 2010 and August 2011, at the Clinic for Thoracic and Cardiovascular Surgery in Bad Oeynhausen, Germany. The devices implanted were the HeartMate II (Thoratec, Pleasanton, CA, USA), the HeartWare HVAD (HeartWare, Oakville, CA, USA) and the Thoratec Paracorporeal BiVAD (Thoratec, Pleasanton, CA, USA). Patients receiving a total artificial heart were excluded from the analysis because, at our institution, the choice to implant a total artificial heart was often based on the presence of mechanical prostheses, active endocarditis, severe pulmonary insufficiency, extensive LV apical thrombus or hypertrophic cardiomyopathy. Patients were also excluded if image quality was deemed insufficient for the analysis of RV function.
Clinical data
Baseline clinical, demographic, haemodynamic and laboratory data were recorded prospectively in the electronic record. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile [14] and Michigan RV risk score [4] were calculated for each patient. The Michigan score assigns points based on four variables, with vasopressor use adding 4 points, creatinine > 2.3 mg/dL adding 3 points, bilirubin > 2 mg/dL adding 2.5 points and aspartate aminotransferase > 80 IU/dL adding 2 points. Higher scores (especially if ≥ 5.5) are associated with a greater risk of RVF.
Patients with a glomerular filtration rate < 60 mL/min/ 1.73 m 2 for 3 months were classified as having chronic renal insufficiency.
Deaths during hospitalization and the causes of death were recorded. Univariate risk factors for death were analysed.
Echocardiographic assessment
Preoperative transthoracic echocardiography results were reviewed and analysed by a reader blinded to clinical outcome. Standard echocardiographic measurements of the RV were made in accordance with current guidelines [15] , including basal RV end-diastolic diameter (RVEDD), endsystolic and end-diastolic RV areas, fractional area change, maximal systolic excursion of the tricuspid annulus (TAPSE), tissue Doppler systolic and diastolic velocities of the RV lateral wall (S RV and E RV ), pulsed Doppler tricuspid E wave (Et), systolic pulmonary arterial pressure and maximal and minimal diameters of the inferior vena cava. Longitudinal strain of the RV free wall was measured on the stored DICOM loops with standard commercially available software (QLAB CMQ, Philips, Amsterdam, Netherlands). Images were searched for evidence of severe mitral, aortic, tricuspid and pulmonary regurgitation. The systolic and diastolic functions of the left ventricle (LV) were also assessed: LV end-diastolic diameter and volume, LV end-systolic diameter and volume, ejection fraction (Biplan Simpson), aortic time-velocity integration, tissue Doppler imaging, systolic and diastolic lateral (S LAT and E LAT ) and septal (S SEPT and E SEPT ) velocities, pulsed Doppler transmitral E wave (Em) and mitral deceleration time.
Several markers were calculated: cardiac index, rightto-left ventricular end-diastolic diameter, Et/E RV ratio, Em/E SEPT ratio, Em/E LAT ratio, Em/S SEPT ratio and Em/S LAT ratio.
Data collection
The data were collected in the 24 hours before LVAD implantation. The median period between admission and VAD implantation was 5.0 days (interquartile range, 2.0-7.0).
Outcomes
Patients were divided into three groups: LVAD patients without RVF, LVAD patients with RVF and patients for whom BiVAD implantation was planned. RVF was defined as the unplanned insertion of a right VAD (RVAD) or the use of an intravenous inotrope for 14 days after surgery [2] [3] [4] [5] [6] [7] [8] 10, 11] .
Statistical analysis
Preoperative variables were compared between the three groups with GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Continuous variables were compared in unpaired t tests for normally distributed variables and Wilcoxon rank-sum tests for non-normally distributed variables. Chi 2 or Fisher's exact tests were used for categorical variables. Analysis of variance was used to compare continuous variables between groups. A P value < 0.05 was considered significant. Relative risks (RRs) are presented with 95% confidence intervals (CIs).
Multivariable analyses were based on stepwise multiple logistic regression analysis and were used to assess predictors of RVF. BiVAD patients were not included in multivariable analyses, because they were generally in a more critical state and the definition of postoperative RVF failure is more complex in this specific context. The following variables were identified as significant predictors (P < 0.05) in univariate analyses between the two LVAD groups and were, therefore, included in multivariable analyses: INTERMACS profile, basal RVEDD, minimal inferior vena cava diameter and Em/S LAT ratio.
Bootstrap estimation with resampling from 1000 simulations (570 simulations for the RVF LVAD group and 430 simulations for the LVAD group without RVF) was used. Univariate and multivariable analysis were performed on bootstrap samples.
An ARVADE (assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures) score was devised by rounding the exponentiated regression model coefficients of independent predictors of RVF to the nearest 0.5. A receiver operating characteristic curve was plotted for ARVADE score, and the area under the curve (AUC) was calculated. AUCs were also calculated for Michigan score and for the independent predictors of RVF.
Results
Population characteristics
During the study period, 67 patients received mechanical circulatory support. We excluded 18 patients because they had received a total artificial heart (11 patients) or because complete echocardiographic evaluations with strain rate imaging were not available (7 patients; all undergoing emergency implantation); thus, 49 patients were included in the study. Twenty-seven patients received the HeartWare HVAD (HeartWare), 15 patients received the HeartMate II (Thoratec) and seven patients received a Thoratec Paracorporeal BiVAD. Detailed results are shown in Table 1 .
Characteristics of the population, according to the presence or absence of a BiVAD
The patients in the BiVAD group were more severely ill at the time of mechanical circulatory support implantation than those of the LVAD groups ( Table 1 ). All BiVAD patients had an INTERMACS level 1 profile and a significantly higher Michigan score than the other patients. BiVAD patients had a significantly lower RV stroke work index and a decreased pulmonary capillary wedge pressure. Finally, concerning echocardiographic variables (Table 2) , diastolic indices (Em, E LAT , Em/E SEPT , Em/S LAT ratio and Em/S SEPT ratio) were increased in the BiVAD population.
Post-implantation RVF in LVAD patients
Twenty-four LVAD patients (57%) developed RVF, 11 of whom required a temporary RVAD.
Outcome
Inhospital mortality rates were 4 of 7 (57%) in the BiVAD group, 8 of 24 (33%) in the LVAD with RVF group and 0 of 18 in the LVAD without RVF group (P < 0.01). The risk factors for death in hospital identified in the univariate analysis were RVF (RR 1.95, 95% CI 1.42-2.66; P = 0.002) and an INTERMACS level 1 profile (RR 1.96, 95% CI 1.09-3.52; P = 0.049).
Risk factors for RVF in LVAD patients
Clinical risk factors for RVF were INTERMACS level and preoperative mechanical ventilation (Table 1 ). Biological and haemodynamic characteristics and Michigan score were similar in patients with and without RVF.
The associations between preoperative echocardiographic characteristics and RVF are reported in Table 2 . Variables assessing RV systolic function (S RV , longitudinal strain and TAPSE) tended to be decreased in RVF patients. Univariate analysis identified the following echocardiographic measurements as risk factors for RVF: basal RVEDD, minimal inferior vena cava diameter, Em, Em/S LAT ratio and Em/S SEPT ratio.
Independent predictors of postoperative RVF
Multivariable analysis identified INTERMACS level 1, the Em/S LAT ratio and the basal RVEDD as independent predictors of RVF (Table 3) . These results were confirmed by bootstrapping.
ARVADE score
An ARVADE score was calculated as the sum of points attributed according to the values of three variables: 3.0 points for Em/S LAT ≥ 18.5, 2.0 points for basal RVEDD ≥ 50 mm and 1.5 points for INTERMACS level 1. An ARVADE score > 3.0 was predictive of post-implantation RVF, with a sensitivity of 89% and a specificity of 74%. Receiver operating characteristic curves for the ARVADE score, the independent RVF predictors identified in our study and the Michigan score are shown in Fig. 1 . In our population, the Em/S LAT ratio was the independent predictor with the best AUC. The ARVADE score outperformed the independent factors identified in our study and the Michigan score in predicting the occurrence of postoperative RVF (Fig. 1 ).
Discussion
The findings of this prospective study indicate that Em/S LAT was the index that most accurately predicted RVF after LVAD implantation, showing that LV echocardiographic variables were the best predictors of post-LVAD RVF. A straightforward score combining the results of preoperative clinical (INTER-MACS level 1) and echocardiographic assessments (Em/S LAT ratio and basal RVEDD) may be a useful predictor of RVF.
RVF incidence
RVF developed after LVAD implantation in 57% of our patients. This figure is high but consistent with published findings.
Different definitions of postoperative RVF have been used in different studies. When we reviewed all studies reporting postoperative RVF (Table 4) [3] [4] [5] [7] [8] [9] [10] [16] [17] [18] [19] [20] [21] , we found at least five definitions of this condition: (A) unplanned insertion of an RVAD or the use of an intravenous inotrope for 14 days after surgery; (B) unplanned insertion of an RVAD or the use of an intravenous inotrope for at least 14 days after surgery or discharge from hospital on inotrope treatment; (C) planned insertion of a BiVAD; (D) unplanned insertion of an RVAD; and (E) presence of two of the following criteria in the first 48 hours after surgery: mean arterial pressure ≤ 55 mmHg, central venous pressure ≥ 16 mmHg, mixed venous saturation ≤ 55%, cardiac index < 2 L/min/m 2 , inotropic support score > 20 units or the need for an RVAD. RVF incidence was between 9 and 49%, depending on the definition used. The definition of postoperative RVF as unplanned insertion of an RVAD yielded a lower incidence, whereas incidences of almost 50% were reported for the definition of RVF as use of an intravenous inotrope for 14 days after surgery or the unplanned insertion of an RVAD. For LVAD patients developing RVF, we obtained an incidence of RVF of 57%, consistent with the three largest studies, which reported RVF incidences of 40% to 50% [3, 8, 21] . We used the most widely used definition here [4, 17, 20, 21] .
RV function in LVAD recipients
After LVAD implantation, adequate RV function is required for pulmonary output and sufficient return to the LV to supply the pump. Nevertheless, in cases of end-stage heart failure and/or cardiogenic shock, there is some degree of RV dysfunction before surgery, clearly increasing the risk of RVF [12, 13] .
RV behaviour after LVAD implantation is difficult to predict. In most patients, RV function improves because the afterload is decreased [9, 22] . However, complex haemodynamic modifications, caused by the leftward shift of the interventricular septum, may affect RV function during LVAD implantation. RV dysfunction may also be favoured by postoperative RV distension, caused by the perioperative use of blood products and crystalloids, and intraoperative RV injury [18] .
RVF in LVAD recipients results in higher mortality [2] . In our study, RVF was associated with inhospital mortality. It is, therefore, important to identify those patients who are likely to develop RVF.
Assessment of RV function
It is difficult to predict the adequacy of RV function and its capacity to respond to variations in loading conditions in LVAD patients before surgery. A: unplanned insertion of a right ventricular assist device (RVAD) or the use of an intravenous inotrope for 14 days after surgery; B: unplanned insertion of an RVAD or the use of an intravenous inotrope for at least 14 days after surgery or hospital discharge on inotrope treatment; C: planned insertion of a biventricular assist device; D: unplanned insertion of an RVAD; E: presence of two of the following criteria in the first 48 hours after surgery: mean arterial pressure ≤ 55 mmHg, central venous pressure ≥ 16 mmHg, mixed venous saturation ≤ 55%, cardiac index < L/min/m 2 , inotropic support score > 20 units or the need for an RVAD; RVF: right ventricular failure. a Data are number (%).
Limitations of biological measurements
Previous studies identified congestion biomarkers, including urea, creatinine, aminotransferase and bilirubin concentrations, and prothrombin time as risk factors for RVF development [4] . However, these markers are not specific for RVF and may reflect poor kidney perfusion and liver congestion in the context of severely decompensated global heart failure. In our population of patients selected for LVAD, neither biological markers nor the Michigan RV score was associated with the post-LVAD risk of RVF. This may be because a high Michigan RV score is used as a criterion for selecting patients for planned BiVAD implantation at our institution. Thus, in our study, the Michigan RV score was higher in the planned BiVAD group than in the other groups. Alternatively, these results may reflect the timing of biological data collection. We recorded biological data on the day of implantation, in patients stabilized, as required, with inotrope treatment. The status of almost all patients was therefore better than that at admission. Previous studies using the Michigan RV score to predict the occurrence of RVF after LVAD implantation did not report the timing of biological data collection [4, 8] .
Invasive haemodynamic measurements
Pulmonary arterial blood pressure, pulmonary vascular resistance, central venous blood pressure and RV stroke work index have been identified as risk factors for RVF [5, 7] . However, the results of different studies diverge and, in our study, no invasive haemodynamic measurement discriminated between LVAD patients with and without RVF, although the RV stroke work index was lower in BiVAD patients. The use of invasive haemodynamic indices to select patients for BiVAD implantation might account for our results.
The value of echocardiographic assessments
Transthoracic echocardiography is non-invasive and readily available at the patient's bedside. However, echocardiographic assessment is particularly difficult for the RV, because of its complex geometry [15] .
RV function variables
Some indices assessing RV systolic function have been identified as predictors of RVF after LVAD implantation; they include TAPSE < 7.5 mm, RV fractional area shortening and longitudinal strain < −9.6% [8] [9] [10] [11] . In our population, these markers were not discriminating. There are several possible reasons for this: previous cardiac surgery (a factor present in 43% of our patients) can interfere with RV systolic indices and/or function [22] , RV function measurements are load dependent and load conditions differed before and after LVAD implantation. Uncertainties concerning delineation of the RV endocardium in some patients may have contributed to our negative results [15] . Basal RVEDD is associated with the risk of developing RVF after LVAD implantation. Thus in our hands, the echocardiographic measurements predictive of RVF after LVAD implantation were not those assessing RV systolic function, but those reflecting RV congestion [9, 10] .
Pulmonary circulatory function variables
Chronic sustained increases in blood pressure in the pulmonary capillaries caused by pulmonary venous congestion and pulmonary venous hypertension lead to RV overload and failure. Variables assessing pulmonary circulatory function have been reported in previous studies aiming to predict RVF after LVAD implantation [4, 5, 13, [18] [19] [20] . In a retrospective analysis assessing 337 patients, pulmonary blood pressure and pulmonary capillary wedge pressure were found to be the most important haemodynamic determinants of RV function in both decompensated and stable systolic heart failure [13] . In our study, among echocardiographic variables, systolic pulmonary pressure failed to differentiate between the different groups, whereas variables assessing the diastolic function of the LV were identified as risk factors for postoperative RVF.
LV function variables
One study to date has highlighted the potential value of assessing LV function for the evaluation of RV function and the identification of patients at risk of RVF after LVAD implantation [12] . This study reported that LV measurements (LV diameters, LV ejection fraction and left atrial diameter/LV end-diastolic diameter ratio) could help to identify patients at risk of developing postoperative RVF.
In our study, some variables assessing LV function were identified as risk factors for RVF after LVAD implantation: Em, Em/S SEPT ratio and Em/S LAT ratio.
The E wave is dependent on fast passive filling and diastolic LV function; a high E wave reflects high capillary wedge pressures and, indirectly, a high RV afterload [23] . A study in 16 anaesthetized dogs with closed chests showed that the E wave was strongly related to LV contractility and afterload (R = 0.906) [24] . This relationship led the authors to conclude that relaxation was closely related to systolic function. We considered the E wave to reflect not only high capillary wedge pressures, but also severe impairments of LV contractility.
Similarly, early E LAT s assessing LV relaxation were also found to differ between BiVAD and LVAD patients.
The normalization of the E wave value by longitudinal function makes a major contribution to the evaluation of LV filling pressure: Em/E LAT and Em/E SEPT ratios [23] . Here, we have expanded this concept slightly, by calculating the Em/S LAT and Em/S SEPT ratios.
The Em/S LAT ratio was the best echocardiographic index for identifying postoperative RVF. A low S LAT reflects severe LV systolic dysfunction. Moreover, it is a load-independent measure [25] .
We would expect that the interventricular septum systolic impairment would be more relevant than the lateral wall and the Em/S SEPT stronger than the Em/S LAT for predicting RVF failure after LVAD implantation. The RV is linked to the LV via the shared septal wall, the pericardial space and the mutually encircling epicardial fibres, and because the RV free wall is attached to the anterior and posterior septum [26] . We find, paradoxically, that Em/S LAT , reflecting LV function, was the index that most accurately predicted RVF after LVAD implantation, showing the strong contribution of the LV to RVF.
RV dysfunction is a consequence of LV dysfunction in cases of end-stage heart failure ischaemic cardiomyopathy, and these two dysfunctions progress together in cases of dilated cardiomyopathy.
As it is difficult to assess RV function, an assessment of LV systolic function can be used to evaluate RV function. LV echocardiographic variables are not affected by cardiac surgery [22] . It is, therefore, not particularly surprising that a LV measurement was the best predictor of RVF after LVAD implantation. Nevertheless, this factor alone does not provide a satisfactory prediction of RVF after LVAD implantation.
The usefulness of a score for predicting RVF in LVAD patients
The large number of factors responsible for RVF after LVAD implantation justify the development of scores for predicting the risk of postoperative RVF [4, 5, 18] .
Our score is a simple tool combining one clinical prognostic marker-the INTERMACS level [14] -and three easily-obtained echocardiographic measurements reflecting RV congestion and LV function. Our score outperformed the Michigan score in our study; these two scores are complementary. Critically ill patients with a high Michigan score should undergo BiVAD implantation. The difficulty in routine clinical practice is identifying the 'less severely ill' patients likely to develop postoperative RVF. The ARVADE score could be useful for this. Prospective validation of this tool with a large population is required before its use can be generalized.
Study limitations
The definition of RVF remains problematic for the classification of patients. Indeed, the definition 'unplanned insertion of an RVAD or the use of an intravenous inotrope for 14 days postoperatively' covers a very large and heterogeneous population.
Other limitations of our study include the small number of patients and the monocentric character of our cohort.
Conclusion
The occurrence of RVF following LVAD implantation is a severe complication, associated with excess mortality.
The echocardiographic variables assessing the LV were the best predictors of post-LVAD RVF, showing the strong contribution of the LV to RVF.
The ARVADE score, calculated as the sum of scores for one clinical prognostic marker (INTERMACS level) and three easily obtainable echocardiographic measures (Em/S LAT and basal RVEDD) reflecting LV global systolic and diastolic dysfunction and RV congestion, may facilitate the identification of suitable patients for device implantation.
